Synopsis
Synopsis
0
CEP/COS
0
JDMF
0
EU WC
0
KDMF
0
NDC API
0
VMF
0
FDF
0
FDF Dossiers
0
FDA Orange Book
0
Europe
0
Canada
0
Australia
0
South Africa
0
Listed Dossiers
DRUG PRODUCT COMPOSITIONS
0
EDQM
0
USP
0
JP
0
Others
0
US Patents
0
US Exclusivities
0
Health Canada Patents
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
0
News #PharmaBuzz
US Medicaid
NA
Annual Reports
NA
Finished Drug Prices
NA
1. 17 Beta Hydroxy 5 Beta Androstan 3 One
2. 17 Beta-hydroxy-5 Beta-androstan-3-one
3. 17beta Hydroxy 5alpha Androstan 3 One
4. 17beta-hydroxy-5alpha-androstan-3-one
5. 5 Alpha Dht
6. 5 Alpha Dihydrotestosterone
7. 5 Alpha-dihydrotestosterone
8. 5 Beta Dihydrotestosterone
9. 5 Beta-dihydrotestosterone
10. 5-alpha Dihydrotestosterone
11. 5-alpha-dht
12. Anaprotin
13. Andractim
14. Beta-hydroxy-5 Beta-androstan-3-one, 17
15. Dihydroepitestosterone
16. Dihydrotestosterone
17. Dihydrotestosterone, 5-alpha
18. Gelovit
19. Stanolone
1. Stanolone
2. Dihydrotestosterone
3. 521-18-6
4. Andractim
5. Anabolex
6. Androlone
7. Neodrol
8. 4-dihydrotestosterone
9. 5alpha-dihydrotestosterone
10. Anaboleen
11. Proteina
12. Stanaprol
13. Protona
14. Cristerona Mb
15. 17beta-hydroxy-5alpha-androstan-3-one
16. Dht
17. Androstanolona
18. Androstanolonum
19. 5alpha-androstan-17beta-ol-3-one
20. 5-alpha-dihydrotestosterone
21. Testosterone, Dihydro-
22. 4,5alpha-dihydrotestosterone
23. Stanorone
24. Dihydrotestosteron
25. 17beta-hydroxyandrostan-3-one
26. 5alpha-dht
27. 17beta-hydroxy-3-androstanone
28. Dihydrotestosterone (dht)
29. Nsc 10972
30. 5alpha,17beta-hydroxyandrostan-3-one
31. Androstanolone [inn]
32. Chebi:16330
33. 17-beta-hydroxy-5-alpha-androstan-3-one
34. 5alpha-dihydrotesosterone
35. 5alpha Dihydrotestosterone
36. Nsc-10972
37. Androstan-3-one, 17-hydroxy-, (5alpha,17beta)-
38. 5.alpha.-dihydrotestosterone
39. 5alpha-androstan-3-one, 17beta-hydroxy-
40. Chembl27769
41. (5s,8r,9s,10s,13s,14s,17s)-17-hydroxy-10,13-dimethyl-1,2,4,5,6,7,8,9,11,12,14,15,16,17-tetradecahydrocyclopenta[a]phenanthren-3-one
42. 4,5.alpha.-dihydrotestosterone
43. (5alpha,17beta)-17-hydroxyandrostan-3-one
44. 17beta-hydroxy-androstan-3-one
45. 5-alpha-androstan-3-one, 17-beta-hydroxy-
46. 521-18-6 (free)
47. Androstan-3-one, 17-hydroxy-, (5a,17b)-
48. 17.beta.-hydroxy-3-androstanone
49. 08j2k08a3y
50. Androstanolone (inn)
51. 17beta-hydroxy-5alpha-androstane-3-one
52. 5.alpha.-androstan-17.beta.-ol-3-one
53. Ncgc00091013-01
54. Stanolon
55. 5.alpha.,17.beta.-hydroxyandrostan-3-one
56. Dsstox_cid_2364
57. Dsstox_rid_76558
58. Dsstox_gsid_22364
59. [3h]dht
60. 5alpha-dihydroxytestosterone
61. Androstan-17beta-ol-3-one
62. Androstanolonum [inn-latin]
63. (5s,8r,9s,10s,13s,14s,17s)-17-hydroxy-10,13-dimethylhexadecahydro-3h-cyclopenta[a]phenanthren-3-one
64. Cas-521-18-6
65. Androstanolona [inn-spanish]
66. 4,5-alpha-dihydrotestosterone
67. 5-.alpha.-androstanolone
68. 5.alpha.-androstan-3-one, 17.beta.-hydroxy-
69. 17-hydroxyandrostan-3-one
70. [3h]dihydrotestosterone
71. [3h]-dihydrotestosterone
72. Einecs 208-307-3
73. 5alpha,17eta-hydroxyandrostan-3-one
74. Androstan-17.beta.-ol-3-one
75. 5-alpha-androstan-17-beta-ol-3-one
76. 17-beta-hydroxyandrostan-3-one
77. Androstan-3-one, 17-hydroxy-, (5.alpha.,17.beta.)-
78. Andrin
79. Unii-08j2k08a3y
80. (+)-androstan-17.beta.-ol-3-one
81. 1kdk
82. 2ama
83. (5-alpha,17-beta)-17-hydroxyandrostan-3-one
84. Andractim (tn)
85. (5s,8r,9s,10s,13s,14s,17s)-17-hydroxy-10,13-dimethyltetradecahydro-1h-cyclopenta[a]phenanthren-3(2h)-one
86. 5-a-androstanolone
87. 5alpha-androstanolone
88. 5a-dihydrotestosterone
89. 17-.beta.-hydroxy-5-.alpha.-androstan-3-one
90. 5-alpha-androstanolone
91. 1d2s
92. 1t5z
93. 1t7r
94. Stanolone [mi]
95. (5.alpha.,17.beta.)-17-hydroxy-androstan-3-one
96. 4,5a-dihydrotestosterone
97. Androstan-17b-ol-3-one
98. Epitope Id:135868
99. 17-hydroxyandrostan-3-one, (5.alpha.,17.beta.)- #
100. Ec 208-307-3
101. 17b-hydroxy-3-androstanone
102. Bidd:pxr0075
103. Schembl15163
104. 17-hydroxy-androstan-3-one
105. Mls001304063
106. 5a-androstan-17b-ol-3-one
107. Bidd:er0136
108. 5.alpha.-dihydroxytestosterone
109. 5a-androstan-3-on-17b-ol
110. 5b-androstan-3-on-17b-ol
111. Androstanolone [mart.]
112. Gtpl2856
113. Gtpl3455
114. Androstanolone [who-dd]
115. Dtxsid9022364
116. Bdbm18161
117. 1t63
118. (+)-androstan-17beta-ol-3-one
119. Hms2272h05
120. Amy22298
121. Hy-a0120
122. Nsc10972
123. Zinc3814360
124. Tox21_111056
125. Tox21_200987
126. Tox21_303655
127. Bdbm50366473
128. Lmst02020042
129. S4757
130. Akos015894892
131. Ccg-267385
132. Cs-5096
133. Db02901
134. Gs-6587
135. Ncgc00091013-02
136. Ncgc00091013-03
137. Ncgc00257456-01
138. Ncgc00258540-01
139. 17beta-hydroxy-3-oxo-5alpha-androstanone
140. Ac-16144
141. Ac-33095
142. Smr000058342
143. Testosterone Impurity F [ep Impurity]
144. 5alpha-androstan-17beta-ol-3-one, >=97.5%
145. C03917
146. D07456
147. 521s186
148. Q411054
149. 17.beta.-hydroxy-5.alpha.-androstan-3-one
150. 17.beta.-hydroxy-5.alpha.-androstane-3-one
151. Androstanolone (5alpha-dihydrotestosterone; Stanolone)
152. 5alpha-androstan-17beta-ol-3-one, Purum, >=99.0% (tlc)
153. 5alpha-androstan-17beta-ol-3-one 100 Microg/ml In Acetonitrile
154. 5alpha-androstan-17beta-ol-3-one, Vetranal(tm), Analytical Standard
155. Androstanolone (5alpha-dihydrotestosterone; Stanolone) 1.0 Mg/ml In Acetonitrile
156. (1s,2s,7s,10r,11s,14s,15s)-14-hydroxy-2,15-dimethyltetracyclo[8.7.0.0;{2,7}.0;{11,15}]heptadecan-5-one
157. (1s,2s,7s,10r,11s,14s,15s)-14-hydroxy-2,15-dimethyltetracyclo[8.7.0.0^{2,7}.0^{11,15}]heptadecan-5-one
158. (5s,8r,10s,13s,17s)-17-hydroxy-10,13-dimethyl-hexadecahydro-cyclopenta[a]phenanthren-3-one
159. 17-hydroxy-10,13-dimethyl-1,2,4,5,6,7,8,9,10,11,12,13,14,15,16, 17-hexadecahydrocyclopenta[a]phenanthren-3-one
160. 5alpha-dihydrotestosterone (dht) Solution, 1.0 Mg/ml In Methanol, Ampule Of 1 Ml, Certified Reference Material
Molecular Weight | 290.4 g/mol |
---|---|
Molecular Formula | C19H30O2 |
XLogP3 | 3.7 |
Hydrogen Bond Donor Count | 1 |
Hydrogen Bond Acceptor Count | 2 |
Rotatable Bond Count | 0 |
Exact Mass | 290.224580195 g/mol |
Monoisotopic Mass | 290.224580195 g/mol |
Topological Polar Surface Area | 37.3 Ų |
Heavy Atom Count | 21 |
Formal Charge | 0 |
Complexity | 459 |
Isotope Atom Count | 0 |
Defined Atom Stereocenter Count | 7 |
Undefined Atom Stereocenter Count | 0 |
Defined Bond Stereocenter Count | 0 |
Undefined Bond Stereocenter Count | 0 |
Covalently Bonded Unit Count | 1 |
Androgens
Compounds that interact with ANDROGEN RECEPTORS in target tissues to bring about the effects similar to those of TESTOSTERONE. Depending on the target tissues, androgenic effects can be on SEX DIFFERENTIATION; male reproductive organs, SPERMATOGENESIS; secondary male SEX CHARACTERISTICS; LIBIDO; development of muscle mass, strength, and power. (See all compounds classified as Androgens.)
A - Alimentary tract and metabolism
A14 - Anabolic agents for systemic use
A14A - Anabolic steroids
A14AA - Androstan derivatives
A14AA01 - Androstanolone
G - Genito urinary system and sex hormones
G03 - Sex hormones and modulators of the genital system
G03B - Androgens
G03BB - 5-androstanon (3) derivatives
G03BB02 - Androstanolone
Absorption
Bioavailability is very low (0-2%) following oral administration.
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 2596
Submission : 1976-01-16
Status : Inactive
Type : II
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 16907
Submission : 2003-10-15
Status : Inactive
Type : II
USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others
USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 8954
Submission : 1991-01-30
Status : Inactive
Type : II
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 8954
Submission : 1991-01-30
Status : Inactive
Type : II
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 16907
Submission : 2003-10-15
Status : Inactive
Type : II
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 2596
Submission : 1976-01-16
Status : Inactive
Type : II
About the Company : Aspen API is the cooperative entity formed by Aspen Oss in the Netherlands and Fine Chemicals Corporation in South Africa. With quality, compliance, and teamwork at its core, Aspen...
About the Company : Symbiotec, a leading API manufacturing company based in Indore, Central India, specializes in Cortico-Steroids and Steroid-Hormone APIs. Since 1995, their focus on R&D, sustainable...
About the Company : Aasraw Biochemical Technology Co.,ltd was reorganized by a Shanghai based Biochemical Engineering Laboratory in 2008, which was built by 5 Chinese Ph. Doctors, who are majored at C...
API Imports and Exports
Importing Country | Total Quantity (KGS) |
Average Price (USD/KGS) |
Number of Transactions |
---|
Upgrade, download data, analyse, strategize, subscribe with us
Market Place
Reply
03 Nov 2021
Reply
31 Aug 2018
ABOUT THIS PAGE
A Dihydrotestosterone manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Dihydrotestosterone, including repackagers and relabelers. The FDA regulates Dihydrotestosterone manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Dihydrotestosterone API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
click here to find a list of Dihydrotestosterone manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.
A Dihydrotestosterone supplier is an individual or a company that provides Dihydrotestosterone active pharmaceutical ingredient (API) or Dihydrotestosterone finished formulations upon request. The Dihydrotestosterone suppliers may include Dihydrotestosterone API manufacturers, exporters, distributors and traders.
click here to find a list of Dihydrotestosterone suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
A Dihydrotestosterone DMF (Drug Master File) is a document detailing the whole manufacturing process of Dihydrotestosterone active pharmaceutical ingredient (API) in detail. Different forms of Dihydrotestosterone DMFs exist exist since differing nations have different regulations, such as Dihydrotestosterone USDMF, ASMF (EDMF), JDMF, CDMF, etc.
A Dihydrotestosterone DMF submitted to regulatory agencies in the US is known as a USDMF. Dihydrotestosterone USDMF includes data on Dihydrotestosterone's chemical properties, information on the facilities and procedures used, and details about packaging and storage. The Dihydrotestosterone USDMF is kept confidential to protect the manufacturer’s intellectual property.
click here to find a list of Dihydrotestosterone suppliers with USDMF on PharmaCompass.
Dihydrotestosterone Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Dihydrotestosterone GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Dihydrotestosterone GMP manufacturer or Dihydrotestosterone GMP API supplier for your needs.
A Dihydrotestosterone CoA (Certificate of Analysis) is a formal document that attests to Dihydrotestosterone's compliance with Dihydrotestosterone specifications and serves as a tool for batch-level quality control.
Dihydrotestosterone CoA mostly includes findings from lab analyses of a specific batch. For each Dihydrotestosterone CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Dihydrotestosterone may be tested according to a variety of international standards, such as European Pharmacopoeia (Dihydrotestosterone EP), Dihydrotestosterone JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Dihydrotestosterone USP).
LOOKING FOR A SUPPLIER?